Hot Features
Cardiovascular Sciences Inc., a technology company, focuses on the development of medical products. Its products include Anti Adhesion Technology products to prevent post surgical scarring; Pyruvate Therapy, a patented method for treating patients suffering from cardiac trauma, such as ischemic repe... Cardiovascular Sciences Inc., a technology company, focuses on the development of medical products. Its products include Anti Adhesion Technology products to prevent post surgical scarring; Pyruvate Therapy, a patented method for treating patients suffering from cardiac trauma, such as ischemic reperfusion injury, heart failure, and bypass surgery; Thromboresistant Coating that prevents blood clot formation on medical devices; a biocompatible Human Vascular Tissue Equivalent for artery replacement during heart surgeries; and patented Aortic Catheters. The company was formerly known as Beverly Hills Weight Loss and Wellness, Inc. and changed its name to Cardiovascular Sciences, Inc. in May 2006. Cardiovascular Sciences is based in Orlando, Florida. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 4379 | 0.0001 | CS |
| 4 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 4379 | 0.0001 | CS |
| 12 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 3171 | 0.0001 | CS |
| 26 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 1890 | 0.0001 | CS |
| 52 | 0 | 0 | 0.0001 | 0.0001 | 1.0E-6 | 1129 | 7.653E-5 | CS |
| 156 | 0 | 0 | 0.0001 | 0.0001 | 1.0E-6 | 2160 | 6.712E-5 | CS |
| 260 | -0.0002 | -66.6666666667 | 0.0003 | 0.375 | 1.0E-6 | 11204 | 0.00028239 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.